UCB Ventures — 2020 Investments

1 investments dated 2020 · listed companies and verified rows first · show all

Walden Bioscienceswaldenbiosciences.com inOct 2020

Walden Biosciences is a clinical-stage biotech company developing disease-modifying therapies that selectively target the kidney to treat the underlying drivers of kidney disease.

BiotechMedical Devices

Co-investorsARCH Venture Partners ATEM Capital Fund Pandect Bioventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.